Hutch News
Results per Page:
There’s no crystal ball for modeling the pandemic
Mathematical modelers explain challenges, limitations of their work to predict COVID-19 outcomes
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of February 21, 2021
Community engagement in HIV trials guides equity for COVID-19 vaccine studies
New study highlights longstanding barriers to diversity in prior decade of vaccine trials, despite federal guidelines
New study highlights lack of diversity and inclusion in vaccine clinical trials
Analysis shows certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed
Calling in the backup: expanding DCs to augment vaccine responses
From the Fling and Cheever CITN Central Immune Monitoring Lab, Vaccine and Infectious Disease Division and Clinical Research Division
Hutch research helps launch new genomic medicine company
Ensoma receives $70 million in financing to develop genome modification technologies via a single injection
Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel
The newly-approved CAR T-cell therapy was developed in part by Fred Hutch physician-scientists
Selective stimulation of neoantigen-specific T cells by immunotherapy
From the Riddell Lab, Clinical Research Division
Closer to the clinic: Modeling ovarian cancer metastases after surgery
From the Greenberg Lab, Clinical Research Division
Scientists predict progress against COVID-19, cancer in 2021
After a challenging and deadly 2020, some hopeful predictions for the new year
Bridging the gap: bispecific proteins for targeted radiotherapy
From the Orozco Laboratory, Clinical Research Division
T cell diversity as a measure of immune recovery following CBT
From the Cord Blood Group and colleagues, Clinical Research Division
Advances in blood disorders research continue despite COVID-19
Expanding use of CAR T-cell therapies, gene editing lead to insights at virtual annual meeting of the American Society of Hematology
Repair of key immune organ triggered by change in how immune cells die
Scientists learn how dying T cells promote regrowth of thymus
Dr. Stanley Riddell awarded Burke O'Reilly Family Endowed Chair in Immunotherapy
Inspired by child's life-threatening illness, family's gift funds development of next-gen therapies
New protocols, precision approaches ahead for lung cancer
Hutch researchers launch liquid biopsy study; large biomarker protocol publishes, providing ‘roadmap’ for treatment of metastatic patients
If at first you don’t succeed: Testing outcomes of second CAR T-cell infusions
From the Turtle group and collaborators, Clinical Research Division
Sifting through the haystack: Optimizing hematopoietic stem cell purification for gene therapy
From the Kiem Lab, Clinical Research Division
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test
Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
Breast cancer researchers from Hutch / UW Cancer Consortium gain BCRF funding
New grants will support studies aimed at bettering patient outcomes through diet, exercise, vaccines and more
Cancer clinical trials: Creativity in the face of COVID-19
Faced with a global pandemic, scientists prioritize safety, patient benefit